Recap: Relmada Therapeutics Q4 Earnings
Recap: Relmada Therapeutics Q4 Earnings
Relmada Therapeutics (NASDAQ:RLMD) reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:15 PM.
Relmada Therapeutics（纳斯达克股票代码：RLMD）于2024年3月19日星期二下午4点15分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Relmada Therapeutics missed estimated earnings by -1.0%, reporting an EPS of $-0.84 versus an estimate of $-0.83.
Relmada Therapeutics报告的每股收益为-0.84美元，未达到预期的-1.0％，而预期的收益为-0.83美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.18 which was followed by a 0.0% increase in the share price the next day.
上个季度，该公司的每股收益高出0.18美元，随后第二天股价上涨了0.0％。
To track all earnings releases for Relmada Therapeutics visit their earnings calendar here.
要追踪Relmada Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。